Catalyst Wire Dossier Catalyst Wire Dossier

RKI983 Eye Drops

RKI983 · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RKI983 Eye Drops, covering 2007-12-28 to 2007-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension [Phase 1]

See pricing